PBP 2a mutations producing very-high-level resistance to beta-lactamsKATAYAMA, Yuki; ZHANG, Hong-Zhong; CHAMBERS, Henry F et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 453-459, issn 0066-4804, 7 p.Article

Carbapenems: Past, Present, and FuturePAPP-WALLACE, Krisztina M; ENDIMIANI, Andrea; TARACILA, Magdalena A et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 11, pp 4943-4960, issn 0066-4804, 18 p.Article

Exposure to diverse antimicrobials induces the expression of qnrB1, qnrD and smaqnr genes by SOS-dependent regulationBRIALES, A; RODRIGUEZ-MARTINEZ, J. M; VELASCO, C et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 12, pp 2854-2859, issn 0305-7453, 6 p.Article

Prolonged β-Lactam Infusion for Gram-negative InfectionsTAMMA, Pranita D; JENH, Alice M; MILSTONE, Aaron M et al.The Pediatric infectious disease journal. 2011, Vol 30, Num 4, pp 336-337, issn 0891-3668, 2 p.Article

A Bacteroides thetaiotamicron porin that could take part in resistance to β-lactamsBEHRA-MIELLET, J; CALVET, L; DUBREUIL, L et al.International journal of antimicrobial agents. 2004, Vol 24, Num 2, pp 135-143, issn 0924-8579, 9 p.Article

New developments in carbapenemsKATTAN, J. N; VILLEGAS, M. V; QUINN, J. P et al.Clinical microbiology and infection. 2008, Vol 14, Num 12, pp 1102-1111, issn 1198-743X, 10 p.Article

Assessing substrate acceptance and enantioselectivity of yeast reductases in reactions with substituted α-keto β-lactamsYAN YANG; KAYSER, Margaret M; ROCHON, Fernande D et al.Journal of molecular catalysis. B, Enzymatic. 2005, Vol 32, Num 5-6, pp 167-174, issn 1381-1177, 8 p.Article

An Ongoing National Intervention to Contain the Spread of Carbapenem-Resistant EnterobacteriaceaeSCHWABER, Mitchell J; CARMELI, Yehuda.Clinical infectious diseases. 2014, Vol 58, Num 5, pp 697-703, issn 1058-4838, 7 p.Article

PBP5, PBP6 and DacD play different roles in intrinsic β-lactam resistance of Escherichia coliKUMAR SARKAR, Sujoy; DUTTA, Mouparna; CHOWDHURY, Chiranjit et al.Microbiology (Reading). 2011, Vol 157, pp 2702-2707, issn 1350-0872, 6 p., 9Article

Importance of Infusion Volume and Pump Characteristics in Extended Administration of β-Lactam AntibioticsCLAUS, Barbara; BUYLE, Franky; ROBAYS, Hugo et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 11, issn 0066-4804, p. 4950Article

Ceftobiprole: a new β-lactam antibioticSTEIN, R. A; GOETZ, R. M; GANEA, G. M et al.International journal of clinical practice (Esher). 2009, Vol 63, Num 6, pp 930-943, issn 1368-5031, 14 p.Article

DoripenemPATERSON, David L; DEPESTEL, Daryl D.Clinical infectious diseases. 2009, Vol 49, Num 2, pp 291-298, issn 1058-4838, 8 p.Article

Efficacy and safety of cefepimeTOWNE, Trent G; LEWIS, James S; ECHEVARRIA, Kelly et al.Lancet. Infectious diseases (print). 2009, Vol 9, Num 1, pp 4-7, issn 1473-3099, 4 p.Article

Identification and Characterization of NocR as a Positive Transcriptional Regulator of the β-Lactam Nocardicin A in Nocardia uniformisDAVIDSEN, Jeanne M; TOWNSEND, Craig A.Journal of bacteriology. 2009, Vol 191, Num 3, pp 1066-1077, issn 0021-9193, 12 p.Article

Model system to evaluate the effect of ampD mutations on AmpC-mediated β-lactam resistanceSCHMIDTKE, Amber J; HANSON, Nancy D.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 6, pp 2030-2037, issn 0066-4804, 8 p.Article

Antimicrobials : The threat of antibiotic resistance in Gram-negative pathogenic bacteria : β-lactams in peril!THOMSON, Jodi M; BONOMO, Robert A.Current opinion in microbiology. 2005, Vol 8, Num 5, pp 518-524, issn 1369-5274, 7 p.Article

High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitutionCARTELLE, Monica; DEL MAR TOMAS, Maria; MOLINA, Francisca et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 2308-2313, issn 0066-4804, 6 p.Article

Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinamLOKRANTZ, C.-M; ERIKSSON, B; ROSEN, I et al.Acta neurologica scandinavica. 2004, Vol 109, Num 4, pp 297-301, issn 0001-6314, 5 p.Article

Efficacité comparable de l'azithromycine en trois jours de prise à la pénicilline V administrée pendant dix joursMédecine & enfance. 2004, Vol 24, Num 3, pp 4-5, issn 0291-0233, 2 p., SUPArticle

Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological propertiesHAMMOND, Milton L.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, pp ii7-ii9, issn 0305-7453, SUP2Article

Importance respective, pour les usages thérapeutiques, des antibiotiques correspondant aux gènes de résistances utilisés. Discussion = Respective importance, for therapeutic uses, of antibiotics corresponding to genes of resistanceGUTMANN, Laurent; SIMONET; ZALTA et al.Science update. 2001, pp 157-162, isbn 2-7380-0967-0Conference Paper

Résistance bactérienne aux β-lactamines = Bacterial resistance to β-lactam antibioticsCHARLIER, P; COYETTE, J; GOFFIN, C et al.MS. Médecine sciences. 1998, Vol 14, Num 5, pp 544-555, issn 0767-0974Article

Limitations of beta-lactam therapy for infections caused by susceptible Gram-positive bacteriaENGLISH, B. Keith.The Journal of infection. 2014, Vol 69, issn 0163-4453, S5-S9, SUP1Conference Paper

Managing Transmission of Carbapenem-Resistant Enterobacteriaceae in Healthcare Settings: A View From the TrenchesPALMORE, Tara N; HENDERSON, David K.Clinical infectious diseases. 2013, Vol 57, Num 11, pp 1593-1599, issn 1058-4838, 7 p.Article

β-Lactams and Florfenicol Antibiotics Remain Bioactive in Soils while Ciprofloxacin, Neomycin, and Tetracycline Are NeutralizedSUBBIAH, Murugan; MITCHELL, Shannon M; ULLMAN, Jeffrey L et al.Applied and environmental microbiology (Print). 2011, Vol 77, Num 20, pp 7255-7260, issn 0099-2240, 6 p.Article